|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00383 TIANAN MEDICARE
Nominal 
0.810 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 827,097 | 5.614% | 1,638,180 | 1,627,199 | 1,568,824 | 1,437,863 |
| Cost of Sales | (657,144) | 5.229% | (1,328,632) | (1,290,979) | (1,278,490) | (1,172,307) |
| Gross Profit | 169,953 | 7.129% | 309,548 | 336,220 | 290,334 | 265,556 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 59,842 | 153.417% | (469) | 57,004 | 40,805 | (117,169) | |
| Taxation | (7,062) | -20.428% | (20,337) | (15,028) | (14,912) | (1,976) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (5,419) | 96.341% | (6,010) | (13,203) | (11,215) | (4,429) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 47,361 | 295.367% | (26,816) | 28,773 | 14,678 | (123,574) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | (1,594) | 32.944% | 575 | (3,383) | 23,341 | 55,057 |
| Depreciation & Amortisation | 47,674 | 5.532% | 93,474 | 97,307 | 92,817 | 104,693 |
| Directors' Emoluments | -- | -- | 4,298 | 4,766 | 4,992 | 3,290 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 4.420 | 298.198% | -2.480 | 2.650 | 1.590 | -16.940 |
| DPS (cts) | 0.000 | -- | 0.000 | 2.000 | 1.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | 75.472% | 62.893% | -- |
| Cash flow per share ($) | -- | -- | 0.117 | 0.098 | 0.385 | 0.097 |
| NBV per share ($) | 1.745 | -- | 1.641 | 1.675 | 1.665 | 2.124 |
| Remarks: | Real time quote last updated: 18/08/2026 08:53 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 47,361 |
| %Change | 295.367% |
| EPS / (LPS) | HKD 0.044 |
| NBV Per Share ($) | HKD 1.745 |